Answers are grounded in this paper and cite their sources.
Once viewed solely as a site for the degradation of biomolecules and damaged cell organelles, the lysosome is now recognised as a key organelle that links nutrient availability to cellular metabolism. Its ability to break down materials and its signalling roles work together. They sense nutrients, regulate metabolism, and monitor the condition of proteins and organelles. The structural and functional complexity positions the lysosome as a dynamic hub that integrates environmental cues into cellular decision-making. Alteration in the lysosomal composition, acidification and trafficking has emerged as a key driver of lysosome-related disease. Apart from lysosome storage disorders, evidence indicates that lysosomal dysfunction leads to neurodegeneration, cancer, metabolic disease, and immune dysregulation and acts as an active contributor to cellular stress. Recent advances in chemical biology and targeted drug delivery have transformed the lysosome from a pathological liability to a therapeutic opportunity. Emerging techniques exploit the lysosomal pathway to modulate autophagy, enable lysosome-directed drug delivery, and target protein degradation, overcoming the limitations of traditional pharmacology. However, the therapeutic applications possess challenges like lysosomal overload, context-dependent toxicity and unknown long-term side effects. This review summarizes current knowledge in lysosomal structure, composition and functions, explores the evolving landscape of lysosome-associated diseases, and highlights future opportunities to harness lysosomal biology for therapeutic innovation.
No takes yet. Share an insight, caveat, or question.
Saha et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: